市场调查报告书
商品编码
1542625
全球血液筛检市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测Global Blood Screening Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球血液筛检市场需求预计将从 2023 年的 47.4 亿美元达到近 134.7 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 12.32%。
血液筛检是在实验室中进行的医疗过程,对捐赠者的血液进行各种感染检测。捐血前进行血液筛检,以便在输血前检查是否有受感染的血液。常见的血液筛检测试包括血型或血型、HIV 和怀孕。此外,血液筛检有助于监测疾病和其他病毒感染。
传染病患者病率的上升和捐血意识的提高正在推动全球血液筛检市场的成长。此外,随着核酸检测和医疗保健的日益普及,人们对安全捐血的认识不断提高,预计将进一步扩大市场需求。然而,高昂的初始成本和营运成本以及缺乏熟练的血液筛检专业人员可能会阻碍市场的成长。然而,在血液筛检过程中采用病原体减少技术预计将在预测期内刺激市场。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球血液筛检市场的每个细分市场进行了包容性评估。血液筛检产业的成长和趋势为这项研究提供了整体方法。
血液筛检市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲血液筛检市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。血液筛检市场的主要参与者包括 Abbott、Danaher Corporation (Beckman Coulter)、Becton Dickinson And Company、Bio-Rad Laboratories Inc.、Hoffman-La Roche Ltd.、Grifols, SA、Ortho-Clinical Diagnostics Inc.、Siemens Healthcare GmbH、Thermo Fisher Scientific Inc.、Sofina SA(生物梅里埃)。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Blood Screening Market is presumed to reach the market size of nearly USD 13.47 Billion by 2032 from USD 4.74 Billion in 2023 with a CAGR of 12.32% under the study period 2024-2032.
Blood screening is a medical process performed in a laboratory where a donor's blood is tested for various infections. Blood screening is performed prior to blood donation in order to check for infected blood before transfusion. The common blood screening tests are blood group or type, HIV, and pregnancy. Further, blood screening helps to monitor diseases and other viral infections.
The rising prevalence of infectious diseases and increasing awareness regarding blood donations is propelling the global blood screening market growth. Also, raising awareness among people regarding safe blood donation along with the increasing adoption of nucleic acid testing and healthcare is further anticipated to augment the market demand. However, high initial and operating cost and lack of skilled professionals in blood screening can hinder the market growth. Whereas, the adoption of pathogen reduction technology in the blood screening process is expected to stimulate the market over the forecast period.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood Screening. The growth and trends of Blood Screening industry provide a holistic approach to this study.
This section of the Blood Screening market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Blood Screening market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood Screening market include Abbott, Danaher Corporation (Beckman Coulter), Becton Dickinson And Company, Bio-Rad Laboratories Inc., Hoffman-La Roche Ltd., Grifols, S.A., Ortho-Clinical Diagnostics Inc., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Sofina S.A (Biomerieux). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.